Clinical Cancer Research The Science of Cancer Health Disparities
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsubayashi, H.
Right arrow Articles by Goggins, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsubayashi, H.
Right arrow Articles by Goggins, M.
Clinical Cancer Research Vol. 11, 573-583, January 2005
© 2005 American Association for Cancer Research


Imaging, Diagnosis, Prognosis

Age- and Disease-Related Methylation of Multiple Genes in Nonneoplastic Duodenum and in Duodenal Juice

Hiroyuki Matsubayashi1,6, Norihiro Sato1, Kieran Brune1, Amanda Lapides Blackford5, Ralph H. Hruban1,2, Marcia Canto3, Charles J. Yeo4 and Michael Goggins1,2,3

Departments of 1 Pathology, 2 Oncology, 3 Medicine, and 4 Surgery and 5 Division of Biostatistics, Johns Hopkins Medical Institutions, Baltimore, Maryland and 6 Fourth Department of Internal Medicine, Tokyo Medical University, Shinjuku, Tokyo, Japan

Requests for reprints: Michael Goggins, Department of Pathology, Johns Hopkins Medical Institutions, 632 Ross Building, 720 Rutland Avenue, Baltimore, MD 21205-2196. Phone: 410-955-3511; Fax: 410-614-0671; E-mail: mgoggins{at}jhmi.edu.

Purpose: Methylation of CpG islands contributes to gene silencing during cancer development, and although some methylation alterations are promising diagnostic markers of cancer, some CpG islands are also methylated in normal tissues. We have previously observed that some normally unmethylated CpG islands that undergo methylation in pancreatic cancers are normally methylated in the adjacent duodenum. Because duodenal methylation patterns are an important consideration when sampling pancreatic tissues for pancreatic cancer methylation alterations, we determined the DNA methylation patterns of 24 genes in the normal duodenum of patients with pancreatic disease and related these patterns to demographic factors.

Experimental Design: The nonneoplastic duodenal mucosa of 158 patients with pancreatic carcinoma and 41 patients with chronic pancreatitis was analyzed using methylation-specific PCR and combined bisulfite restriction analysis. Secretin-stimulated pancreatic/duodenal juice from 15 individuals undergoing endoscopic investigation for upper gastrointestinal disease was also analyzed.

Results: Low-level methylation was detectable by methylation-specific PCR in the nonneoplastic duodenum of many patients with pancreatic cancer and chronic pancreatitis as well as in the pancreaticoduodenal secretions of patients without pancreaticobiliary disease. For many genes, the prevalence of methylation increased with age and was more prevalent in patients with pancreatic cancer than in age-matched patients with chronic pancreatitis.

Our results indicate that strategies to detect pancreatic cancer using aberrantly methylated genes should rely on analysis of pure pancreatic juice rather than on pancreatic juice collected within the duodenal lumen. Patients who develop pancreatic cancer may have a greater propensity to methylate CpG islands than age-matched controls.

Key Words: duodenum • pancreatic carcinoma • chronic pancreatitis • duodenal juice • methylation • smoking • aging




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y. Liu, R. E. Brand, V. Turzhitsky, Y. L. Kim, H. K. Roy, N. Hasabou, C. Sturgis, D. Shah, C. Hall, and V. Backman
Optical Markers in Duodenal Mucosa Predict the Presence of Pancreatic Cancer
Clin. Cancer Res., August 1, 2007; 13(15): 4392 - 4399.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
V. Sebastiani, F. Ricci, B. Rubio-Viquiera, P. Kulesza, C. J. Yeo, M. Hidalgo, A. Klein, D. Laheru, and C. A. Iacobuzio-Donahue
Immunohistochemical and Genetic Evaluation of Deoxycytidine Kinase in Pancreatic Cancer: Relationship to Molecular Mechanisms of Gemcitabine Resistance and Survival
Clin. Cancer Res., April 15, 2006; 12(8): 2492 - 2497.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Matsubayashi, M. Canto, N. Sato, A. Klein, T. Abe, K. Yamashita, C. J. Yeo, A. Kalloo, R. Hruban, and M. Goggins
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
Cancer Res., January 15, 2006; 66(2): 1208 - 1217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.